Lanean...
High-dose Cyclophosphamide and Rituximab without Stem Cell Transplantation: a Feasibility Study for Low Grade B cell, Transformed and Mantle Cell Lymphomas
Relapse after autologous stem cell transplantation for low-grade B-cell lymphoma is common secondary to ineffective conditioning and/or tumor autograft contamination. We investigated high-dose cyclophosphamide and rituximab without stem cell rescue as first-line or salvage-therapy in lymphomas. Afte...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3390263/ https://ncbi.nlm.nih.gov/pubmed/21756035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.594191 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|